Skip to main content
. 2009 Oct 21;468(1):120–126. doi: 10.1007/s11999-009-1128-8

Table 2.

Study outcomes

Study outcomes Coumadin continued (N = 38) Coumadin discontinued (N = 39) Unadjusted risk ratio* (95% confidence interval) Age-adjusted risk ratio (95% confidence interval)
Additional procedure type, number (%)
 I & D 1 (3) 1 (3)
 PRS flap 1 (3)
Additional procedure required, number (%)
 Yes 1 (3) 2 (5) 0.51 0.43
 No 37 (97) 37 (95) (0.01–9.86) (0.01–9.18)
Complication type, number (%)
 Dehiscence 1 (3)
 Hematoma 1 (3) 1 (3)
 Infected open wound 1 (3)
 None 37 (97) 36 (92)
Complication occurred, number (%)
 Yes 1 (3) 3 (8) 0.34 0.29
 No 37 (97) 36 (92) (0.01–4.26) (0.01–4.26)
Transfusion (units), number (%)
 0 30 (79) 29 (74)
 1 1 (3) 2 (5)
 2 7 (18) 6 (15)
 4 2 (5)
Transfusion required, number (%)
 Yes 8 (21) 10 (26) 0.82 0.61
 No 30 (79) 29 (74) (0.28–2.31) (0.20–1.86)
Transfusion (units)
 Mean ± SD 0.4 ± 0.8 0.6 ± 1.1 0.70 0.50
 Median (IQR) 0 (0–0) 0 (0–1) (0.34–1.41) (0.23–1.06)

* Risk ratio is warfarin continued postoperative proportion, or mean, over warfarin preoperative only proportion, or mean, from an exact Poisson regression model; risk ratio is from an exact Poisson regression model that includes age (continuous variable) as a covariate; I & D = irrigation and debridement; PRS = plastic and reconstructive surgery; SD = standard deviation; IQR = interquartile range.